Newark, New Castle, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Intraoperative Radiation Therapy Market was estimated at US$ 54.58 billion in 2021 and is expected to surpass a valuation of US$ 91.74 billion by 2030, progressing at a CAGR of 5.9% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenario, wavering market trends, market size, statistics & estimations, and major investment pockets. Owing to the increasing cancer incidence, new product approvals, and continuous advancements in technology, states Growth Plus Reports.
Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/intraoperative-radiation-therapy-market/8153
Market Drivers
The adoption of unhealthy lifestyles that would cause an increase in cancer cases primarily drives the global intraoperative radiation therapy market. Another element pushing rapid technological improvement is rising morbidity and death from cancer. As nuclear medicines, like radiotherapy, are utilized in cancer treatment, there is an increased need for nuclear medicine radioisotopes, boosting the intraoperative radiation therapy market. Furthermore, expanding clinical trials investigating the use of intraoperative radiation treatment for various cancer applications are likely to provide market participants with attractive development prospects. There is also an improvement in synchronization with other equipment such as robotic arms, as well as with staff and surgeons, which might assist enhance the intraoperative radiation treatment industry. The leading players are concentrating on advancing intraoperative radiation treatment techniques, which will help the market development in the coming years.
The global intraoperative radiation therapy market has been analyzed from four perspectives: Technology, Application, Products & Services, and Region.
Excerpts from ‘By Technology Segmentation’
Based on technology, the global intraoperative radiation therapy market is bifurcated into:
- Electron Intraoperative Radiation Therapy
- Intraoperative Brachytherapy
Because of its numerous benefits, such as shorter treatment duration, higher penetration depth, and optimum dose uniformity, electron intraoperative radiation therapy led the market with the highest revenue share in 2021. Electron intraoperative radiation treatment refers to the application of electron radiation directly to the residual tumor or tumor bed following cancer surgery. Because the dosage decreases rapidly after the target region, electron beams are useful for intraoperative radiation treatment, protecting underlying healthy tissue. Electron intraoperative radiation therapy is safer and more precise, and it saves both the hospital and the patient time. As a result, the advantages of electron intraoperative radiation therapy are propelling segment growth.
Excerpts from ‘By Application Segmentation’
Based on the application, the global intraoperative radiation therapy market is segmented into:
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head And Neck Cancer
- Others
Breast cancer had the largest market share in 2021, owing to reasons such as the non-invasive nature of radiation, the growing prevalence of breast cancer, and the excellent success rates attained with IORT. Major firms are continuously working on launching new and novel technology for treating breast cancer, eventually boosting the market. In March 2022, Zeiss Medical Technology, a global pioneer in ophthalmology and microsurgery, launched the Intrabeam 600 device in India to treat breast cancer with intraoperative radiation therapy. The gadget provides the least invasive therapy option for individuals with early-stage breast cancer. The Intrabeam 600 gadget represents a significant advancement in the treatment of early-stage breast cancer in women. The Intrabeam 600 IORT method takes about 45 minutes to perform one session during a surgery.
Browse Complete Report Details with Full TOC: https://www.growthplusreports.com/report/intraoperative-radiation-therapy-market/8153
Excerpts from ‘By Products & Services Segmentation’
Based on the products & services, the global intraoperative radiation therapy market is segmented into:
- Accelerators
- planning systems
- Applicators
- Afterloaders
- Accessories
- IORT services
Because they are the primary and most commonly used treatment equipment, accelerators held the largest market share in 2021. Linear accelerators charge subatomic particles along a linear path using high-energy radiofrequency electromagnetic waves. A modulator, gantry, electron gun, RF power supply, and accelerator guide are the main components of these accelerators. Linear accelerators can aid in the development of IMRT, IGRT, 3D conformal radiation (3D-CRT), and stereotactic technologies. Linear accelerators, considered the most advanced radiotherapy devices, accurately produce, and distribute radiation in critical treatments such as intensity-modulated and intraoperative radiation therapy. These factors are expected to further boost the accelerator segment.
Excerpts from ‘By Region Segmentation
Based on region, the global intraoperative radiation therapy market has been segmented into
- North America
- Europe
- Asia Pacific
- Rest of the World
North America dominated the global intraoperative radiation therapy market in 2021, primarily due to rising healthcare expenditure and growth, increased cancer awareness, and great reimbursement policies. In addition, the North American area has regular collaborations, and mergers & acquisitions, which aids the North America intraoperative radiation therapy market growth. In May 2022, Brainlab, a digital medical technology business, announced today the acquisition of medPhoton GmbH, a Salzburg, Austria-based company that develops and manufactures robotic imaging solutions for image-guided radiation treatment and surgery. The acquisition seeks to improve Loop-X’s as a 3D imaging equipment for surgery, providing surgeons with access to cutting-edge technology for patient care.
Excerpts from ‘Competitive Landscape’
Some prominent players operating in the global intraoperative radiation therapy market are
- Carl Zeiss MEDITEC AG
- IntraOp Medical Inc.
- Ariane Medical Systems Ltd.
- Eckert & Ziegler
- Varian Medical Systems Inc.
- Sensus Healthcare iCAD Inc.
- Elekta AB
- S.I.T. - Sordina IORT Technologies S.p.A.
- GMV
- Brainlab AG
- REMEDI Co., Ltd.
- Sensus Healthcare
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecast Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL INTRAOPERATIVE RADIATION TECHNOLOGY MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
- Electron Intraoperative Radiation Therapy
- Intraoperative Brachytherapy
- GLOBAL INTRAOPERATIVE RADIATION Technology MARKET - ANALYSIS & FORECAST, BY APPLICATION
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head and Neck Cancer
- Other
TOC Continued..
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy now complete report here: https://www.growthplusreports.com/checkout-8153
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
Manan Sethi Director, Market Insights Email: sales@growthplusreports.com 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/
